Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 AUD | 0.00% | +4.27% | -8.50% |
Mar. 19 | Morgan Stanley Upgrades Baby Bunting to Overweight from Equalweight; Price Target is AU$2.20 | MT |
Feb. 20 | Baby Bunting Shares Drop 12% as H1 FY24 Revenue Declines 2.5%, Profit Slips | MT |
Valuation
Fiscal Period: Juli | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 271.8 | 426.1 | 744.5 | 537.8 | 185.5 | 246 | - | - |
Enterprise Value (EV) 1 | 269.1 | 412.7 | 743.6 | 694.7 | 356.1 | 417.7 | 418.9 | 427 |
P/E ratio | 21.9 x | 45.8 x | 44.3 x | 28.4 x | 19.4 x | 23.9 x | 13.3 x | 10.8 x |
Yield | 3.91% | 3.14% | 2.45% | 3.94% | 6.55% | 3.03% | 4.83% | 6.16% |
Capitalization / Revenue | 0.74 x | 1.05 x | 1.59 x | 1.06 x | 0.35 x | 0.48 x | 0.45 x | 0.42 x |
EV / Revenue | 0.73 x | 1.02 x | 1.59 x | 1.37 x | 0.68 x | 0.82 x | 0.76 x | 0.72 x |
EV / EBITDA | 9.93 x | 12.2 x | 10.6 x | 17 x | 5.34 x | 7.15 x | 6.16 x | 5.47 x |
EV / FCF | 18.1 x | 9.94 x | 30 x | 15.9 x | 9.56 x | 19 x | 16 x | 13.1 x |
FCF Yield | 5.51% | 10.1% | 3.34% | 6.28% | 10.5% | 5.27% | 6.25% | 7.64% |
Price to Book | 2.77 x | 4.56 x | 6.91 x | 4.67 x | - | 2.24 x | 2.05 x | 1.87 x |
Nbr of stocks (in thousands) | 126,441 | 127,564 | 129,255 | 132,458 | 134,906 | 134,439 | - | - |
Reference price 2 | 2.150 | 3.340 | 5.760 | 4.060 | 1.375 | 1.830 | 1.830 | 1.830 |
Announcement Date | 8/15/19 | 8/13/20 | 8/12/21 | 8/11/22 | 8/10/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: July | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 368 | 405.2 | 468.4 | 507.3 | 524.3 | 510.2 | 548.2 | 592 |
EBITDA 1 | 27.12 | 33.7 | 70.2 | 40.95 | 66.7 | 58.42 | 67.98 | 78.1 |
EBIT 1 | 22.09 | 23.46 | 42.3 | 35.29 | 30.23 | 22.76 | 32.88 | 40.81 |
Operating Margin | 6% | 5.79% | 9.03% | 6.96% | 5.77% | 4.46% | 6% | 6.89% |
Earnings before Tax (EBT) 1 | - | - | 23.3 | 28.3 | 15.23 | 17.9 | 26.2 | 33.9 |
Net income 1 | 12.41 | 9.986 | 17.5 | 19.52 | 9.854 | 9.901 | 16.36 | 22.46 |
Net margin | 3.37% | 2.46% | 3.74% | 3.85% | 1.88% | 1.94% | 2.98% | 3.79% |
EPS 2 | 0.0980 | 0.0730 | 0.1300 | 0.1430 | 0.0710 | 0.0766 | 0.1371 | 0.1698 |
Free Cash Flow 1 | 14.83 | 41.53 | 24.81 | 43.62 | 37.25 | 22 | 26.2 | 32.6 |
FCF margin | 4.03% | 10.25% | 5.3% | 8.6% | 7.1% | 4.31% | 4.78% | 5.51% |
FCF Conversion (EBITDA) | 54.7% | 123.24% | 35.34% | 106.52% | 55.85% | 37.66% | 38.54% | 41.74% |
FCF Conversion (Net income) | 119.55% | 415.89% | 141.77% | 223.45% | 378.02% | 222.21% | 160.12% | 145.13% |
Dividend per Share 2 | 0.0840 | 0.1050 | 0.1410 | 0.1600 | 0.0900 | 0.0554 | 0.0884 | 0.1128 |
Announcement Date | 8/15/19 | 8/13/20 | 8/12/21 | 8/11/22 | 8/10/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: July | 2020 S1 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 186.4 | 217.3 | 251.1 | - | 268.2 | 254.9 | 269.4 | - | 257 |
EBITDA 1 | 25.8 | - | - | - | 24.26 | 28.3 | 38.4 | - | 35.7 |
EBIT 1 | 13.5 | - | 22.75 | - | 21.56 | 11.32 | 18.9 | 9.556 | 16.7 |
Operating Margin | 7.24% | - | 9.06% | - | 8.04% | 4.44% | 7.02% | - | 6.5% |
Earnings before Tax (EBT) | - | - | - | - | 17.83 | - | - | - | - |
Net income | - | - | - | 8.147 | 11.37 | 2.709 | - | - | - |
Net margin | - | - | - | - | 4.24% | 1.06% | - | - | - |
EPS | 0.0380 | 0.0560 | - | 0.0580 | 0.0850 | 0.0200 | - | - | - |
Dividend per Share | 0.0410 | - | 0.0830 | - | 0.0900 | 0.0660 | 0.0270 | - | - |
Announcement Date | 2/13/20 | 2/11/21 | 8/12/21 | 2/10/22 | 8/11/22 | 2/16/23 | 8/10/23 | - | - |
Balance Sheet Analysis
Fiscal Period: July | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 157 | 171 | 172 | 173 | 181 |
Net Cash position 1 | 2.7 | 13.3 | 0.9 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | 3.832 x | 2.557 x | 2.939 x | 2.543 x | 2.317 x |
Free Cash Flow 1 | 14.8 | 41.5 | 24.8 | 43.6 | 37.3 | 22 | 26.2 | 32.6 |
ROE (net income / shareholders' equity) | 16% | 20.8% | 25.8% | 17.7% | 13% | 10.3% | 15.5% | 18.4% |
ROA (Net income/ Total Assets) | 9.87% | 7.49% | 9.29% | 6.78% | 4.18% | 4.35% | 6.1% | 7.3% |
Assets 1 | 125.7 | 133.3 | 188.4 | 287.9 | 236 | 227.6 | 268.2 | 307.7 |
Book Value Per Share 2 | 0.7800 | 0.7300 | 0.8300 | 0.8700 | - | 0.8200 | 0.8900 | 0.9800 |
Cash Flow per Share 2 | 0.2000 | 0.3700 | 0.2700 | 0.3000 | 0.3100 | 0.4200 | 0.4400 | 0.5000 |
Capex 1 | 10.5 | 8.32 | 12.1 | 8.75 | 5.76 | 7.37 | 8.77 | 9.82 |
Capex / Sales | 2.85% | 2.05% | 2.58% | 1.72% | 1.1% | 1.44% | 1.6% | 1.66% |
Announcement Date | 8/15/19 | 8/13/20 | 8/12/21 | 8/11/22 | 8/10/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.50% | 160M | |
+27.38% | 29.56B | |
+4.90% | 5.71B | |
-11.42% | 4.42B | |
+14.25% | 4.17B | |
+4.23% | 1.85B | |
-4.59% | 1.77B | |
-13.78% | 1.26B | |
-17.17% | 1.15B | |
-2.08% | 613M |
- Stock Market
- Equities
- BBN Stock
- Financials Baby Bunting Group Limited